Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
Sanjay Singh Institute of Life Sciences, School of Science and Technology, Ahmedabad University, Ahmedabad, Gujarat, India Abstract: Therapeutic agents aimed at inhibiting a single molecular target have not been successful in cancer therapy, but rather they impart resistance. However, multi-target...
Guardado en:
Autor principal: | Singh S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0fddc80cf1e046f99472a75fe1b0011d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma
por: Ju RJ, et al.
Publicado: (2016) -
Preclinical toxicological study of long-circulating and fusogenic liposomes co-encapsulating paclitaxel and doxorubicin in synergic ratio
por: Marjorie Coimbra Roque, et al.
Publicado: (2021) -
Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma
por: Wi TI, et al.
Publicado: (2020) -
Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
por: Franco YL, et al.
Publicado: (2018) -
Angiogenesis and Tumor Progression Inhibition of Cyclooxygenase-2 Selective Inhibitor Celecoxib Associated with Poly (lactic-co-glycolic acid) in Tumor Cell Line Resistant to Chemotherapy
por: Roa,Ignacio, et al.
Publicado: (2017)